World Point-of-Care Diagnostics Market Outlook to 2025 – Increasing Number of Regulatory Approvals for Novel Immunoassay Techniques

by NASDAQ Market News January 4, 2021

NASDAQ Market News
Click here to email author

TLC Announces Completion of US$15 Million Financing for Subsidiary InspirMed Inc.

Tiziana Life Sciences plc (“Tiziana” or the “Company”) – Tiziana announces completion of the clinical trial with nasally administered Foralumab, its proprietary fully human anti-CD3 monoclonal antibody, for the treatment of COVID-19 patients in Brazil

Ads